{"name":"Zai Lab (Hong Kong), Ltd.","slug":"zai-lab-hong-kong-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQUkRHRVN2ejlfTGcwSUFvWXNWSGpmQ2NSRU1PeFF0YTJMczIydm1QM0YzY1lRcVF3SXBGeU9ZaW9XNmJ2RjI5UFVRSWdUTE1fbUZCR2VuMGVDWE4yRWcyMXBoZGJ5RUdjcDZoYV9lSWFwVWwyc1UzVFRrWjV2Sm5WZWFBZ2RTdjhHaFEzV1lmT2FPQjB0bHNiMkowMXlrTWo2ZDU4T0RFUVRpV2VNbGNnMTBLUENBdnlHR1FuTERWZFdlNi1UWkIxRjRTVUs0UFpDSW9MUGFBNHdBeTZaVWhzUG5wQU1YQQ?oc=5","date":"2025-12-24","type":"regulatory","source":"TechStock²","summary":"Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025 - TechStock²","headline":"Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPTW5WNnF3QkRTRFQ0cDRJSEpKQnE4ZUJQTVdtRW42enlJLUFvdjVDVHVQM25SdDQtc1ZkbFlOWmFUS0tISFpZRTZOMmx6VTJ6Y3pReUctZmozSTEtZFFyMmZrY2ZZSy02TVNJcm9XWlpOZVg3cWpCbjRDQUxjektjeXpIU3lHQnZkSjhqMVpYOXBDQ2pkTEZOQWFJVGtmN0szU3ViUTl2eEM5M2tJcm1zZXk3LWlKOWxnZy1rZXV4X1A5WlJCZ0tKNGx1dVpKRDJQZ2l2dldqX29veDN6cEduMlNhU3NWdmxNeTRBNkEzSXVENXVlSEFqY3lITzJERzQ?oc=5","date":"2025-09-12","type":"deal","source":"Citeline News & Insights","summary":"The Rise In China Deals: How International Biopharma Is Turning To China For Innovation - Citeline News & Insights","headline":"The Rise In China Deals: How International Biopharma Is Turning To China For Innovation - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPUzNEcEpSb2Q0RkVlaGZ1ZXQ5a2dnRHBSU3VZQldnNE1kS2Y0ZjVQVHdiXzhmaEFtUWRrRGFvZTdMTjB6cEhOMmtlcm9seWZpbHBfa2l2T2Y4WXU4RHZnVmtlc29XN1E4bldFSDRzR1hqSkdLTmRIeE9sQmxjMXpuSU9sb3pRSy1LVFRTYVFkMFNDZw?oc=5","date":"2025-09-11","type":"pipeline","source":"thebambooworks.com","summary":"Zai Lab under pressure over clinical results and rival drugs - thebambooworks.com","headline":"Zai Lab under pressure over clinical results and rival drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9DaHVUbjNQOTFGNXZuNnNpLUNGR2dMMnBpS1ViZkJ2TDZRZ3FCalRDYXYtU0k2VUx5T1Fycnh6Q1hnbm90RTVybUp6aExNbHlqalNz?oc=5","date":"2025-09-04","type":"regulatory","source":"FirstWord Pharma","summary":"Survival benefit for Amgen's bemarituzumab in gastric cancer drops at final analysis - FirstWord Pharma","headline":"Survival benefit for Amgen's bemarituzumab in gastric cancer drops at final analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQdF9lcnBFS1VpWi05TWRCb3VKWk9hakEyQVZ2UldlZVpoUG1zT3p4X2tWXzJwQ2c2Y3Q5Y05kRnE1aHBjbjR3czRINEpXOC1NeUVYSHJyejBPLVMwQm81a0F0Y21KdXNaZDEzd3JNci1uZFYzX2VYaEs0bHJMV1lCaTJiRDlWb2ZkYVRZTUJ0SFpaSFR3RkxJc3FGb2l1X2VxeEVPa1ZfeGM3SUdRUm9r?oc=5","date":"2025-06-30","type":"trial","source":"Fierce Biotech","summary":"Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 - Fierce Biotech","headline":"Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFA3UEozQnJoNEpGcnk3Mzk3al9QSlhhTjVTbGxIdnJyemVvRFNTdjVINkc3LWJ0ZmZCMVhsb2hmUllmWksyRHVxUlNOakZ2WDhiTnJqTm4yczVIZzJUN3poaDZB?oc=5","date":"2025-06-12","type":"pipeline","source":"globaltimes.cn","summary":"China's innovative drug companies rallying on stock market, driven by strength in global market penetration - globaltimes.cn","headline":"China's innovative drug companies rallying on stock market, driven by strength in global market penetration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxOZ19iVjR0d3pSLXltaGxycWExdEJQVGFpR3p0Z1ZMRF8xSFNhN19hQl9pVGo0QlV4eTdMZlVINjkwR25TTS1PV2xOVzJEV1k1ejlkeUs2Y0w5X05EYnh1M3ZLSFFNS3U2ejloYWZlbXozdmphSVJ2TUlrOWlDQjVEcVVObXFrRlZnekdfWTBubWliWmhXcDRfS29GVVZmZ2RycXg2dDlxTU9NYkMwQ0tFTWJudnNOeDJTTmUtNDdLMHMzRU1jRkRIX1o4RDQ4VDhaNzlkLUI0a2JaX3drV3JmQVpMRVAzdXd2Rms3X2lTaDFfMVRudmd4MF9KSFFhZzFVU21fZG9KcTE1T0Nqdm5Qbjh2RXlHQkUwdHN2V0hoR1VfX2lJQWI0NFpHQW9CakhjODh5emxla1ZtM2hP?oc=5","date":"2025-01-10","type":"pipeline","source":"businesswire.com","summary":"Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - businesswire.com","headline":"Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOc3RjeEFaUGxXeHVYSlc0dFFvTGtXM2UzbWx2NGpOdExqbjVmR2F3WVpfZkd6ajV2Wk9maWhoRE5QQkJYbEJqN09hOS1Ld1A2R3JrVjNjaWU2eVBSVlVDV003OVdyTkR3czg1T3dTcnBwSlczOEpaTmlqZlZEazB1Zw?oc=5","date":"2025-01-10","type":"deal","source":"The Pharma Letter","summary":"Vertex out-licenses povetacicept to Zai Lab - The Pharma Letter","headline":"Vertex out-licenses povetacicept to Zai Lab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPU2J5VmltTHp0cjhHTkM3TVV6SGExVW5qdjVTdW15MVVqWGVjdGtrYXYzWUVEZC1JOHJMZUxIRkRmM0NzT2RVLVd0anBUZ3dIdll6MThMaFZUNjNtWWhtX18yanlMcHF4TmZOUko2WEMxZEtfLXJlUlhvU2ltN3Bjd0JicE92ekVXM1loOWJfeTBVZGZCN3Iza2poZ3cwTnJwOVVQdk1TVFFTbzNVNlRqTjZNd1pOUGdPOG81SlJfTzJvVzd5a0VrQUltakVkMWRJQmVLcUpYS1pOUTRFRkpMbw?oc=5","date":"2025-01-10","type":"deal","source":"BioSpectrum Asia","summary":"Vertex and Zai Lab enter into partnership to treat autoimmune diseases in China, Taiwan, Singapore - BioSpectrum Asia","headline":"Vertex and Zai Lab enter into partnership to treat autoimmune diseases in China, Taiwan, Singapore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPOGl2WDg3NGhVQXUwd0FvcGhXamJJNVdCQzFDQ0g2QVo5Q1pkSWE2SXF2MHcwR1k0d0dtdUxZMXdqeTNsdTBON3RfVTVKM001TEdGVFYtcjJlRDNONHRIX2p3RHZGYk9Xc3dBcGM2ekZOUk0zZ2RhVUtlS0RkdEI5MGZHcGtsNlZwUVRCZEhQMllSeTZGeGNrekhrN3p0NlVRYlZtYXNPNVBoOWJwaC1ZUUV2UFpDVHBYTFNuY1NrRQ?oc=5","date":"2024-11-22","type":"pipeline","source":"Fierce Pharma","summary":"As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact - Fierce Pharma","headline":"As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQcjZPOFdlMnRYZXgxXzJyY1pHOVgzSmF1OGNweUdUNVE4VmJwUUo2NU5TSjlKLTRRb1o5eGdScHo5RHF4VDVvYnhOU3VOTU94S2pIOXJvOXd3RTktRDFuM3BmQnRUOVhvZGdJcmhWRkNDRVNPN1IwcF9wSDc4ci1JeUJ4RkNUdGJfanNFUGM1LS1SYy1GWXRVYmZwenpHVWQ1?oc=5","date":"2022-09-28","type":"pipeline","source":"The Business Journals","summary":"A Chinese pharma plans fast expansion of Cambridge HQ - The Business Journals","headline":"A Chinese pharma plans fast expansion of Cambridge HQ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQX2szRi1md29fNzNpSFRIMWU3VzdoMFllRXdUdzVtUEpoNUdILTN0d0c0d3hpX3o1dlpaRDJjNnhfdHlncHlNTHkwQ20xYm1LUTNudEQteUY2NXp0VS00THNXQWJlaXpOOXhnVU41T1VwcUJrZGs1S3pRY1V6NWdXVXFlWWYtUkhUdDVQTGJDMmhzTkN6cDNkT05uOGRRSTRlcWhGTF9fVURENVkwYkVB?oc=5","date":"2017-09-27","type":"earnings","source":"Bloomberg.com","summary":"China's Revenue-Free Drug Trip - Bloomberg.com","headline":"China's Revenue-Free Drug Trip","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}